The company aims to provide medical-aesthetic services, particularly the performance of beauty treatments such as wrinkle injections with botulinum toxin (Botox®) and hyaluronic acid, as well as other minimally invasive procedures in the field of aesthetic medicine. The company may engage in all transactions that are directly or indirectly related to this purpose, including providing consulting services, conducting training, and selling products in the field of aesthetic medicine. The company may establish branches and subsidiaries both domestically and abroad, and may participate in other companies both domestically and abroad, as well as engage in all transactions that are directly or indirectly related to its purpose. The company may acquire, encumber, dispose of, and manage real property both domestically and abroad, as well as acquire, manage, and dispose of intellectual property rights and licenses. It may also arrange financing for its own or third-party account, as well as provide security for the liabilities of affiliated companies.